Ibritumomab Intravenous and Vantrela ER
Determining the interaction of Ibritumomab Intravenous and Vantrela ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: hydrocodone
Brand name: Hysingla ER, Vantrela ER, Zohydro ER
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Vaprisol
- Ibritumomab Intravenous-Vaqta
- Ibritumomab Intravenous-Vaqta Pediatric
- Ibritumomab Intravenous-Vardenafil
- Ibritumomab Intravenous-Vardenafil Hydrochloride
- Ibritumomab Intravenous-Vardenafil ODT
- Vantrela ER-Ibritumomab Tiuxetan
- Vantrela ER-Ibrutinib
- Vantrela ER-Ibrutinib Capsules
- Vantrela ER-Ibrutinib Tablets
- Vantrela ER-Ibu
- Vantrela ER-IBU Tablets